Search Results for "oppenheimer" OPYOppenheimer$90.02 -1.44 (-1.57%) Closing price 11/12/2026 03:59 PM EasternExtended Trading$89.64 -0.38 (-0.42%) As of 11/12/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ExchangeNYSESectorFinanceIndustryCapital MarketsMarket Capitalization$979.54 millionP/E Ratio12.12Consensus RatingBuyDividend Yield0.87%View Full ProfileStock ForecastEarningsDividendsInsider TradesInstitutional OwnershipSEC FilingsCompetitorsChartEarnings Jan 29Dividend 0.89%AI OverviewBetaAI-generated. Verify before making investment decisions.Loading the AI overviewRelated searchesLatest news on OPYOPY earningsOPY analyst price targetAll Search Results96 resultsTop ResultsCompanies (7)Articles (89)Instant Alerts (20)ShowRelevanceDateSort byOppenheimer (NYSE:OPY) Stock Price, News & AnalysisReal-time quote, price history, analyst ratings, news and financial statements for Oppenheimer.Stock Forecast & Price TargetAnalyst consensus rating, twelve-month price targets and recent upgrades and downgrades.Earnings Date, Estimates & HistoryNext report date, EPS and revenue estimates, and the history of beats and misses.Dividend History & YieldDividend yield, payout history, ex-dividend dates and payout ratio.Insider Buying and SellingForm 4 filings from officers and directors with transaction dates and post-transaction holdings.Ratings by OppenheimerView the latest analyst ratings, stock recommendations and price targets issued by equities research analysts at Oppenheimer.Other Companies Related to 'oppenheimer'FGNAUFGNAUFG New America Acquisition Corp.OPKOPKO Health, Inc.OPAYOPAYOPay Ltd.KODKEastman Kodak CompanyBRKBerkshire Hathaway Inc.VOOVanguard S&P 500 ETFEKDKQEastman KodakSee all 7 companies Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?Viking Therapeutics stock jumped on rumors of a potential acquirer looking to add a GLP-1 treatment to their portfolio and VK2735 appears to rival Zepbound.By Jea Yu·February 26, 2025Occidental Petroleum: Unpacking Its Onshore Oil & Gas StrengthOccidental Petroleum's largest business segment is its onshore oil & gas production with nearly 2.7 million acres in the Permian Basin, here's what's coming.By Jea Yu·April 22, 2025Tesla (TSLA) Recovery May Start Now as Oppenheimer Declares it a “Triple Play”If Tesla (NASDAQ: TSLA) were a car—instead of just being a car maker—it would be one that many would likely be leery of riding in ever again.By Steve Anderson·April 13, 2020OPKO Health is the Little Giant of Diversified Healthcare Diversified healthcare company OPKO Health Inc. (NASDAQ: OPK) shares may be low priced, but its businesses pipeline of treatments and upside potential mayBy Jea Yu·July 19, 2023Oppenheimer: Even Bottomed Prices Aren't Enough to Recommend FedEx (NYSE:FDX)one Oppenheimer analyst suggests that, though FedEx shares have bottomed out, it's still not an attractive buy.By Steve Anderson·December 19, 2019Occidental’s Hidden Gem: How OxyChem Could Boost ProfitsOccidental Petroleum's chemical division OxyChem is an unsung hero that develops products serving industries ranging from healthcare, staples and construction.By Jea Yu·April 29, 2025Oppenheimer Has the Lead on S&P Optimism in 2020Oppenheimer Asset Management, whose analyst John Stoltzfus now predicts that the S&P 500 will hit 3500 at some point in the year,By Steve Anderson·December 17, 20194 deep values for opportunistic investingAnalysts' sentiment helped to lower the share prices of these stocks but the moves are overextended and provide deep value for opportunistic investors.By Thomas Hughes·November 22, 2023Occidental Petroleum: Another bounce from the buy zoneOccidental Petroleum's revenue deleveraged on lower oil prices but production gains and an improving capital structure drove solid cash flow and capital return.By Thomas Hughes·November 8, 2023Occidental’s Billion-Dollar Carbon Credit Plan Takes ShapeOccidental Petroleum is reshaping its image and reliance on oil and gas drilling as it is set to finally launch Stratos in 2025, its first carbon capture plant.By Jea Yu·March 26, 2025Occidental Petroleum Will Move Higher in 2025 Say AnalystsOccidental Petroleum builds shareholder equity while paying down debt and a substantial dividend. Worth nearly 2% in mid-February, this distribution will grow.By Thomas Hughes·Updated February 26, 2025Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?Occidental Petroleum hit a 52-week low in March and may move lower, but investors shouldn't rush to the exits; Berkshire will probably buy more this month.By Thomas Hughes·March 6, 2025Occidental Petroleum stock price is ready to gush higherOccidental Petroleum is executing plans to reduce debt, free cash flow, and return capital to investors through dividend growth and repurchases.By Thomas Hughes·February 15, 2024Occidental Petroleum: 4 Reasons to Love These PricesOccidental Petroleum's stock just hit 52-week lows but the company is making headway into diversifying its oil well inventory and revenue streams.By Jea Yu·March 17, 2025Nuclear Stocks Reach Critical Mass: The Time to Buy Is NowOklo, NuScale Energy, and Centrus Energy are uniquely positioned to benefit from Trump's executive orders for the nuclear energy industry.By Thomas Hughes·May 27, 2025Why Buffett Loves Occidental Stock And What It Means for ChevronBerkshire Hathway continues to buy shares of Occidental Petroleum and sell shares of Chevron, but investors should be careful not to draw the wrong conclusionBy Chris Markoch·October 17, 2024Why Analysts See Big Upside for Occidental Petroleum Despite LowsInvestors worried about the recent sell-offs in Occidental Petroleum stock should consider if this is now a buying opportunity.By Gabriel Osorio-Mazilli·September 6, 2024Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 GrowthAerospace stocks have had a mixed 2024 thanks to Boeing. These 2 smaller aerospace players may be grabbing market share during Boeing's PR nightmare.By Jea Yu·January 9, 2025October’s Big Winners: Top 5 Stocks to Keep on Your RadarFive top stock picks for October offer investors opportunities in artificial intelligence, energy, value, e-commerce, and global technology.By Jeffrey Neal Johnson·October 1, 2024The Only A-Rated Stock with a 7%+ DividendThis pipeline company benefits from a 'toll-both' business model amid a boom in production volume - and growing distributionsBy MarketBeat Staff·May 22, 2024Oppenheimer (NYSE:OPY) Shares Gap Up - Here's WhyOppenheimer (NYSE:OPY) Shares Gap Up - What's Next?Alert·November 4, 2026Oppenheimer (NYSE:OPY) Downgraded by Wall Street Zen to "Hold"Wall Street Zen lowered shares of Oppenheimer from a "buy" rating to a "hold" rating in a report on Saturday.Alert·October 31, 2026Oppenheimer (NYSE:OPY) Stock Crosses Below 200 Day Moving Average - What's Next?Oppenheimer (NYSE:OPY) Shares Break Below 200 Day Moving Average - What's Next?Alert·October 31, 2026Oppenheimer (NYSE:OPY) Stock Falls 14.4% - Should You Sell?Oppenheimer (NYSE:OPY) Shares Down 14.4% - What's Next?Alert·October 30, 2026BILL (NYSE:BILL) Stock Gets Price Target Boost from OppenheimerOppenheimer lifted their price target on BILL from $55.00 to $60.00 and gave the company an "outperform" rating in a research note on Friday.Alert·November 6, 2026The Pennant Group (NASDAQ:PNTG) Given New $50.00 Price Target at OppenheimerOppenheimer raised their price target on shares of The Pennant Group from $47.00 to $50.00 and gave the company an "outperform" rating in a research report on Thursday.Alert·November 5, 2026Atlassian (NASDAQ:TEAM) Stock Price Target Lowered at OppenheimerOppenheimer cut their target price on shares of Atlassian from $275.00 to $240.00 and set an "outperform" rating on the stock in a research note on Friday.Alert·November 6, 2026Oppenheimer Has Lowered Expectations for EMCOR Group (NYSE:EME) Stock PriceOppenheimer reduced their target price on shares of EMCOR Group from $1,200.00 to $1,000.00 and set an "outperform" rating for the company in a report on Monday.Alert·November 2, 2026Oppenheimer Has Lowered Expectations for EverCommerce (NASDAQ:EVCM) Stock PriceOppenheimer lowered their target price on shares of EverCommerce from $13.00 to $11.00 and set an "outperform" rating for the company in a report on Friday.Alert·November 6, 202632,795 Shares of The Pennant Group, Inc. $PNTG Bought by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. bought a new stake in The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 32,795 shares of the company's stock, valued at approximately $1,279,000. Oppenheimer & CAlert·November 2, 2026Buffett's Berkshire Increases Stake In Occidental Petroleum (OXY)Buffett's Berkshire Hathaway increases its stake in Occidental Petroleum, crossing the 25% ownership mark with the recent purchase.By Ryan Hasson·June 30, 2023Occidental Petroleum is a Buy in Q4 2025Occidental Petroleum is set to reduce debt and drive shareholder value, affirming the Buffett investment thesis and potential for triple-digit share gains.By Thomas Hughes·November 12, 2025Occidental Petroleum Pulls Back To The Sweet SpotOccidental Petroleum pulled back to the sweet spot ahead of earnings and is now moving higher, the question is if Warren Buffet is buying now or not.By Thomas Hughes·February 28, 2023Occidental Petroleum Hits New Low: Will Buffett Take the Bait?Occidental Petroleum's share price hits a new low and maybe the bait this market needs to get re-engaged. Cash flow is robust, and debt is falling.By Thomas Hughes·November 14, 2024Uncle Sam Plugs In: Nuclear Energy’s Cash Flow Moment Is Finally HereFederal low-interest credit and long-term corporate purchase agreements are fundamentally transforming nuclear energy into a highly stable growth sector.By Jeffrey Neal Johnson·June 26, 2026Oklo: The Bottom Is In, and the Upside Potential Is NuclearOklo Inc. is on track to commercialize its nuclear empire across fuel, isotope, and energy production, with FY 2025 results affirming a robust growth outlook.By Thomas Hughes·March 19, 2026How Berkshire's OxyChem Buy Cements Its Long-Term StrengthBerkshire Hathaway's multi-billion-dollar acquisition of OxyChem signals a strategic deployment of cash into a stable, long-term industrial earnings engine.By Jeffrey Neal Johnson·October 2, 2025Why Occidental's Price Dip Signals a Buying OpportunityOccidental Petroleum's stock price seems disconnected from its operational success, financial discipline, and leadership in new carbon capture technologies.By Jeffrey Neal Johnson·July 3, 2025Oklo Reaches Critical Mass, Atomic Upside Still AvailableOklo is advancing its Aurora project and remains on track for a late 2027 or early 2028 deployment and commercial operations.By Thomas Hughes·May 14, 2025 Opko Health (NASDAQ: OPK) Stock: Multiple Expansion Breakout FormingDiversified healthcare company Opko Health (NASDAQ: OPK) shares have recently surged to 2018 highs at $6.47 from lows of $1.12 pandemic lows when the S&P 500 index (NYSEARCA: SPY) plunged (-34%) into March 2020.By Jea Yu·August 14, 2020Schrodinger is an AI-Powered Drug Discovery Developer to WatchDrug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117By Jea Yu·March 8, 2023Oklo’s Fuel Partnership Strengthens Bullish Case for StockOklo's strategic agreement with Lightbridge on nuclear fuel strengthens its position in the rapidly growing clean energy market for the future.By Jeffrey Neal Johnson·January 29, 2025Ouster Is Breaking Out as a Physical AI Leader: Here's What's Driving the MoveOUST shares closed at $62.52 on June 30, 2026, extending a 189% year-to-date gain driven by Rev8 lidar compliance with federal infrastructure funding rules and a string of new partnership agreements.By Ryan Hasson·July 1, 20263 Under-the-Radar Defense Stocks With Record BacklogsATI, Astronics, and Ducommun each posted record backlogs amid rising defense spending, but their margins, leverage, and guidance suggest differing abilities to convert orders into profit.By Dan Schmidt·September 7, 2026Oklo Stock: Nuclear Powerhouse or Radioactive Hype?Oklo's innovative approach to nuclear power sparks investor excitement, but significant financial and regulatory hurdles warrant cautious due diligence.By Jeffrey Neal Johnson·October 30, 2024Navy Catalyst Ignites Odysight’s Growth EngineOdysight.ai's landmark U.S. Navy deal and backlog signal a pivotal commercial shift, validating its predictive maintenance technology at an elite level.By Jeffrey Neal Johnson·May 12, 2026Intercepting Growth: Karman Secures $218M Lockheed Martin DealKarman Space & Defense secured a seven-year, $218 million Lockheed Martin contract for missile defense shrouds, offering revenue visibility as insiders buy shares ahead of Q3 earnings.By Jeffrey Neal Johnson·October 21, 2026Insiders Are Selling These 3 High-Flying StocksMP Materials, Oklo, and Redwire are seeing enormous insider selling over the last 1-2 months. See what these sales mean for each name.By Leo Miller·January 19, 2026Occidental Petroleum Leads Exxon Mobil, Chevron Ahead Of Earnings Like Exxon Mobil , Chevron, and other oil-and-gas producers, Occidental Petroleum (NYSE: OXY) has been forming a potentially constructive consolidation,By Kate Stalter·Updated July 28, 2022Rocket Lab's Electron: The Quiet Workhorse Powering MomentumDespite Neutron grabbing the headlines, Electron remains the company’s backbone, with 70 launches to date and expanding multi-launch contracts.By Ryan Hasson·October 2, 2025Cameco's $80 Billion U.S. Nuclear Deal Changes Everything A landmark U.S. government deal for new Westinghouse reactors cements Cameco’s role in the global nuclear renaissance and the AI-driven energy boom.By Jeffrey Neal Johnson·October 31, 2025RTX Is Set to Revolutionize Munitions ManufacturingRTX is actively dismantling the most severe munitions production bottleneck facing the Western defense industrial base through composable propulsion systems.By Jeffrey Neal Johnson·May 28, 2026JPMorgan and Goldman Upgrade MP Materials Amid Defense-Driven Demand OutlookMP Materials stock looks poised for a rebound as analysts see major upside and strategic importance in U.S. defense and rare-earth supply chains.By Thomas Hughes·November 24, 2025Warner Brothers Discovery is a Powerhouse Entertainment PlayMedia entertainment company Warner Brothers Discovery (NYSE: WBD) stock has languished since its spin-off as it fell to new all-time lows at $12.77 .By Jea Yu·August 4, 2022Helmerich & Payne Stock, A Lot More Upside Than Meets the EyeMassive investor benefits coming to HP, along with a revised prediction for higher oil prices pushing further alpha in the stock's target price.By Gabriel Osorio-Mazilli·March 6, 2023AI, Satellites and Staples: Insiders Are Buying and Selling 3 Big NamesFrom the world's preeminent AI chip manufacturer to a soaring space stock not named Rocket Lab, insiders are buying and selling these key names.By Leo Miller·April 13, 2026Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryOklo's insiders sold in Q2 and Q3, but this poses no threat to investors; institutions and analysts offset it, while short-sellers are a bigger risk.By Thomas Hughes·October 2, 2025Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for DronesOuster's Department of Defense win just sent shares skyrocketing. Its OS1 sensor now has Blue UAS approval, allowing a streamlined path for use in DoD drones.By Leo Miller·June 14, 2025Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in FocusNANO Nuclear Energy shares rose after an Air Force SBIR contract for its KRONOS reactor, but a 32% short float and heavy insider selling temper the pre-revenue stock's outlook.By Jeffrey Neal Johnson·July 28, 2026Woodward: Delivering Critical Components for the Aerospace BoomWoodward Inc. reports record 2024 growth. With strong aerospace sales and a promising 2025 outlook, WWD stock presents opportunities for savvy investors.By Jea Yu·December 31, 2024The $100 Barrel Is Back: Trading The Hormuz Havoc Many institutional investors are prioritizing Exxon Mobil Corporation and Chevron Corporation as these firms capture gains from high global oil prices.By Jeffrey Neal Johnson·April 15, 2026Cameco Is the Leading Play on Nuclear Power, And It Pays to OwnCameco is well-positioned to deliver positive cash flow and improve shareholder value as demand for uranium grows. Rising uranium prices are aiding margins.By Thomas Hughes·October 29, 2024Last chance to set up your portfolio for OPEC cuts OPEC is standing strong by its decision to make production cuts, and Goldman Sachs has a higher oil price in their mind. Markets have placed their bets here.By Gabriel Osorio-Mazilli·December 6, 2023Paramount’s 30-Film Promise Puts AMC Back in the Box Office ConversationParamount Skydance's 30-film theatrical guarantee could stabilize cinema chains like AMC, but the plan hinges on its Warner Bros. Discovery merger surviving a March 2027 antitrust trial.By Jeffrey Neal Johnson·August 12, 2026Alcoa’s Gallium Project Opens a New Door Beyond AluminumAlcoa is extracting gallium at its Wagerup refinery to supply tech and defense markets, backed by government funding and a Sojitz off-take deal, while its core aluminum business funds the pivot.By Jeffrey Neal Johnson·August 26, 2026Opal Fuels CEO on Steering the Future of Renewable Natural GasOpal Fuels' vertically integrated RNG model positions the company for substantial long-term growth in the growing renewable energy market.By Jeffrey Neal Johnson·December 20, 2024From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are TradingCheck out these three stocks that insiders are buying and selling, including giants in oil and AI, as well as a small gene stock seeing huge swings.By Leo Miller·June 6, 2026Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Oklo shares rose after Q3 earnings showed progress on its Idaho Aurora project and new revenue, but delays, cash shortfalls, and dilution risks keep analysts cautious.By Thomas Hughes·November 9, 2026Peabody Energy is a Double Threat Energy and Steel Play Peabody Energy Co. (NYSE: BTU) is the nation's largest coal producer supplying energy producers like utilities and steel. The popular decarbonization movementBy Jea Yu·July 11, 2023Buffett’s on the Sidelines – Should You Follow?Warren Buffett moved to cash in 2024 suggesting a stock market correction is due. How deep it gets depends on tariffs, inflation, and the FOMC.By Thomas Hughes·February 26, 2025A Prada Payday: Is AMC Back in Style?AMC Entertainment is seeing renewed bullish momentum, driven by a box-office hit and a critical debt restructuring that extends its financial runway.By Jeffrey Neal Johnson·May 5, 20263 Upgrades Moving Markets Ahead Of Q1 Earnings What’s more, with the outlook for Q2 and Q3 on the rise this situation could linger well into the second half of the year if not beyond and lead the market higher the entire time.By Thomas Hughes·April 5, 2021Coinbase stock and the case for 50% upsideLast Friday, the Oppenheimer team upgraded their rating on Coinbase stock from Perform to Outperform. It's just one of a handful of recent upgrades.By Sam Quirke·January 31, 2024These Consumer Stocks Will Thrive And Here’s Why The outlook for consumer spending is getting darker by the day but the bad news is not universal. While some companies are poorly positioned in regards to inflation, interest rate hikes, and the combined impact on consumer spending there are others that are not.By Thomas Hughes·July 20, 2022Adobe Is Not Just Another Brick In The Wall Adobe’s results for the 3rd quarter ensure the 3rd quarter earnings cycle is going to be an interesting one, the company reported blow-out earnings and garnered the attention of at least ten major sell-side firms.By Thomas Hughes·September 23, 2021Meta’s Muse Agent Has Wall Street Divided on Its AI PotentialMeta's new Muse AI agent boosted shares and app downloads, but analysts at J.P. Morgan, Mizuho, and Oppenheimer disagree on its adoption and monetization potential.By Leo Miller·September 21, 2026Breaking Down Where Wall Street Sees the S&P 500 Going in 2025Wall Street price targets for the S&P 500's year-end 2025 level are out. See where analysts predict the market will go next year.By Leo Miller·December 23, 20243 big banking stocks that just got upgradedBanking stocks are finding themselves more popular than they’ve been in a long time, and it doesn't look like that's going to change anytime soon.By Sam Quirke·January 31, 2024Analysts can't get enough of this Domino's Pizza stockRecent updates from management have gone down a treat, and there's been no shortage of analysts coming out bullish on the stock heading into 2024.By Sam Quirke·December 13, 2023Undervalued Spectrum Brands Moves Higher After UpgradeShares of undervalued consumer staples stock Spectrum Brands are moving higher following an upgrade, read on to find out how high they will go.By Thomas Hughes·April 6, 2021Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?Marinus is an under $2 biotech stock with Wall Street analysts price targets ranging from $2 to $13. Its upcoming trial results have big implications.By Leo Miller·October 1, 20243 reasons 2024 Moderna shareholders may party like it's 2021With interest in Moderna Inc. stock picking up alongside news flow, investors could be in for some very healthy 2024 gains.By MarketBeat Staff·January 5, 2024This Small Cap Stock Surged Over 100%Shares of Eloxx Pharmaceuticals (NASDAQ: ELOX) rocketed almost 100% on Tuesday after receiving an increased price target from Oppenheimer.By Ryan Hasson·July 12, 2023Penny Stock Wag! Group Co. Has Solid Sell-Side SupportWag! Group is an up and comer in the pet services industry that could see a triple-digit increase in its share price this year.By Thomas Hughes·April 5, 2023Is Chipotle Starting To Look Cheap Here?For a stock that has dropped 25% since the middle of September, Chipotle Mexican Grill (NYSE: CMG) is sure attracting a lot of favorable attention.By Sam Quirke·January 20, 2022Sweetgreen Stock is Looking TastyOrganic salad restaurant operator Sweetgreen (NYSE: SG) stock recovering off its recent IPO sell-off as investors take advantage of discounted shares.By Jea Yu·December 28, 2021Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?Amazon’s flat 2025 performance may be setting up a breakout year. With bullish analyst calls, rising AWS momentum, and a low P/E, it looks ready to run.By Sam Quirke·December 2, 2025Mobileye's High Short Interest Signals Squeeze PotentialMobileye is well-positioned within the autonomous driving industry and can take share while deepening penetration with OEMs globally.By Thomas Hughes·January 22, 2025XPO Stock Gains Momentum as U.S. Trade Outlook EvolvesXPO is at the forefront of the transportation and logistics business, with shares that have spiked throughout 2024; here's a glimpse of what may be to come.By Nathan Reiff·December 22, 2024Bargain Alert: 3 Stocks Worth Watching While The Market CoolsFor those of us on the sidelines who remain bullish on equities through the rest of the year and into 2025, this is an entry opportunity.By Sam Quirke·July 25, 2024Jack in the Box and the Case for a 30% RallyAccording to one analyst team at least, now’s not the time to walk away from Jack in the Box, and if anything, it’s time to start getting excited.By Sam Quirke·March 15, 2024Goldman Sachs looks poised for a breakoutThe Goldman Sachs Group's (NYSE: GS) recent outperformance and bullish technical analysis suggest the potential for a breakout, warranting a closer look.By Ryan Hasson·February 6, 2024Corbus Pharmaceuticals stock: An explosive 342% YTD surgeShares of CRBP have already experienced a meteoric rise of over 300% year-to-date, thanks to early but promising data from its Phase 1 trial.By Ryan Hasson·February 5, 2024It's too Soon to Ring the Register on Shopify's Growth StoryShopify is moving higher after Amazon said it would launch a Buy with Prime app on Shopify's app ecosystem; a first for Shopify merchants.By Thomas Hughes·September 6, 2023GXO Logistics Manages Another Buying Opportunity GXO Logistics pulls back into a buying opportunity following strong results and perceived weakness in the guidance, but growth is still on the table.By Thomas Hughes·February 15, 2023Is Wendy’s Stock Uptrend Set To Continue?As investors stare at their portfolio and wonder if it’s in good shape for the coming months, Wendy’s mightn’t be a bad one to keep on the watchlist.By Sam Quirke·January 12, 20233 Stocks Cowen Thinks Are Going HigherEarlier this week, the folks over at Cowen released their findings from a consumer survey of millennials and Generation Z.By Sam Quirke·October 15, 2021Square (NYSE: SQ) On Track To Retake All Time HighsAs equity markets look set to begin reversing four straight weeks of losses, shares of Square (NYSE: SQ) look like they want to end the month as they started it, at all-time highs.By Sam Quirke·September 28, 2020Trading Blueprint for Marvell Technology (MRVL) Stockanalysts at Oppenheimer and Deutsche Bank both made preemptive estimate cuts for MRVL revenue and earnings forecasts to accommodate fallout from coronavirus disruptions to supply chains.By Jea Yu·March 3, 2020Atlassian Corporation PLC $TEAM Stock: Oppenheimer & Co. Inc. Trims PositionOppenheimer & Co. Inc. cut its holdings in Atlassian Corporation PLC (NASDAQ:TEAM - Free Report) by 68.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 6,669 shares of the technology company's stock after selling 14,578 shares during the period. OppenheimerAlert·November 3, 2026Oppenheimer Forecasts Strong Price Appreciation for The PNC Financial Services Group (NYSE:PNC) StockOppenheimer increased their price objective on The PNC Financial Services Group from $269.00 to $274.00 and gave the company an "outperform" rating in a report on Monday.Alert·November 2, 2026Oppenheimer & Co. Inc. Makes New Investment in Affirm Holdings, Inc. $AFRMOppenheimer & Co. Inc. bought a new stake in shares of Affirm Holdings, Inc. (NASDAQ:AFRM - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 14,633 shares of the company's stock, valued at approAlert·November 3, 2026Oppenheimer & Co. Inc. Acquires New Stake in Sprott Physical Gold and Silver Trust $CEFOppenheimer & Co. Inc. bought a new position in shares of Sprott Physical Gold and Silver Trust (NYSEAMERICAN:CEF - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 126,923 sharesAlert·October 30, 2026Oppenheimer Issues Positive Forecast for Sweetgreen (NYSE:SG) Stock PriceOppenheimer increased their price target on shares of Sweetgreen from $8.50 to $14.00 and gave the stock an "outperform" rating in a research note on Friday.Alert·November 6, 2026Echostar CORP $ECHO Stock Sold by Oppenheimer & Co. Inc.Oppenheimer & Co. Inc. cut its stake in shares of Echostar CORP (NASDAQ:ECHO - Free Report) by 90.0% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,622 shares of the company's stock after selling 23,71Alert·November 8, 2026Oppenheimer & Co. Inc. Sells 243,735 Shares of Infleqtion $INFQOppenheimer & Co. Inc. cut its holdings in shares of Infleqtion (NYSE:INFQ - Free Report) by 60.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 160,779 shares of the quantum tech company's stock after selling 243,735 shares durAlert·November 1, 2026Medline $MDLN Stock: Oppenheimer & Co. Inc. Grows PositionOppenheimer & Co. Inc. boosted its holdings in Medline (NASDAQ:MDLN - Free Report) by 1,022.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 60,023 shares of the company's stock after purchasing an additioAlert·November 1, 2026AppLovin (NASDAQ:APP) Stock Keeps "Outperform" Rating at OppenheimerOppenheimer reaffirmed an "outperform" rating and set a $520.00 price target (up from $490.00) on shares of AppLovin in a research note on Thursday.Alert·November 5, 2026Oppenheimer Issues Pessimistic Forecast for Quanta Services (NYSE:PWR) Stock PriceOppenheimer dropped their price objective on shares of Quanta Services from $835.00 to $800.00 and set an "outperform" rating for the company in a report on Monday.Alert·November 2, 2026These results are filtered by type. Click here to see all results.OPYOppenheimer$90.02 -1.44 (-1.57%) Closing price 11/12/2026 03:59 PM EasternExtended Trading$89.64 -0.38 (-0.42%) As of 11/12/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.ExchangeNYSESectorFinanceIndustryCapital MarketsMarket Capitalization$979.54 millionP/E Ratio12.12Consensus RatingBuyDividend Yield0.87%View Full ProfileOPY Quick LinksStock ForecastEarningsDividendsInsider TradesInstitutional OwnershipSEC FilingsCompetitorsChartOppenheimer MarketRank™ Stock Analysis1.95899921404 of 5 starsOverall MarketRank™39th Percentile Analyst RatingBuy Upside/DownsideN/A Short Interest LevelHealthy Dividend StrengthWeak News Sentiment0.22 Insider TradingN/A Proj. Earnings GrowthN/A See Full AnalysisOPY EarningsNext ReportJan 29, 2027, Before Market Opens (est.)Trailing EPS$7.43Earnings history & estimates Health Indicator for Oppenheimer TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, OPY's financial health has been in the Red zone, according to TradeSmith. Oppenheimer Dividend PaymentsDividend Yield0.89% Annual Dividend$0.80 Dividend Increase Track Record1 Year Annualized 5-Year Dividend Growth3.05% Dividend Payout Ratio10.77% Upcoming Ex-Dividend DateNov. 13 OPY Dividend HistoryRecent Analyst RatingsWall Street Zen10/31/2026DowngradeHoldWall Street Zen8/1/2026UpgradeBuyWall Street Zen5/9/2026DowngradeHoldWall Street Zen3/7/2026UpgradeStrong-BuyWall Street Zen11/8/2025DowngradeBuyAll OPY analyst ratingsInsider ActivityDennis P Mcnamara Insider3/2/2026Sell4,673 shares$423.70 thousandDennis P Mcnamara Insider8/5/2025Sell2,000 shares$147.62 thousandPaul M Friedman Director6/9/2025Sell3,500 shares$221.62 thousandDennis P Mcnamara Insider7/31/2024Sell6,000 shares$307.68 thousandAll OPY insider tradesOPY NewsOppenheimer (NYSE:OPY) Shares Gap Up - Here's WhyNov 4, 2026 · AlertOppenheimer (NYSE:OPY) Downgraded by Wall Street Zen to "Hold"Oct 31, 2026 · AlertOppenheimer (NYSE:OPY) Stock Crosses Below 200 Day Moving Average - What's Next?Oct 31, 2026 · AlertAll OPY newsRelated CompaniesBULLWebull$4.84-1.73%ETOReToro Group$22.03-5.51%TOPTOP Financial Group$14.47-8.42%PWPPerella Weinberg Partners$13.73-4.68%LCLNLCLNLincoln International$26.85-0.44%See all competitorsGet Oppenheimer alertsSign Up Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
